Hybrid Membrane Staging for SPTFF Concentration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for concentrating proteins using single pass tangential flow filtration (SPTFF) face limitations in achieving high concentrations and flow rates due to the need for complex staging arrangements and membrane fouling, particularly when dealing with partially retained solutes and completely retained proteins.
Innovation Solution
A hybrid configuration of semi-permeable ultrafiltration membranes with different molecular weight cutoffs (MWCOs) staged in series in a SPTFF apparatus, where the final membrane has a larger MWCO than the preceding membranes, allowing for higher concentration factors and flow rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional batch recirculation mode using ultrafiltration membrane is used, then protein concentration can be achieved, but the operation becomes a batch process with lower productivity and higher operating costs
Solution Approach 1:
The system segments the ultrafiltration process into multiple stages with different MWCO membranes (e.g., 100 kDa, 50 kDa, 30 kDa) arranged in series. Each stage handles a specific concentration range, enabling continuous processing while achieving high final concentrations (100-200 mg/mL) that would be difficult in a single batch step.
Solution Approach 2:
The system dynamically adjusts the membrane configuration based on the concentration stage. Early stages use higher MWCO membranes for rapid bulk concentration, while later stages use lower MWCO membranes for final concentration and buffer exchange, optimizing throughput at each phase of the process.
2Productivity
If single pass tangential flow filtration is used to increase flow rates, then productivity improves, but membrane fouling increases and concentration factors are limited
Solution Approach 1:
The fouling problem is segmented across multiple membranes with different MWCOs. Each membrane operates at an optimal flux range for its specific retention requirement, preventing any single membrane from becoming excessively fouled while maintaining high overall flow rates through the series configuration.
Solution Approach 2:
The system changes the membrane parameter (MWCO) along the flow path, creating a gradient from higher to lower MWCO. This parameter change allows each membrane to operate in its optimal performance window, maintaining high flux rates while managing fouling through the progressive concentration stages.
3Quantity of substance
If complex staging arrangements are used to achieve high concentration factors, then concentration capability improves, but device complexity increases
Solution Approach 1:
The complex concentration task is segmented into manageable stages, each with a specific MWCO membrane. This segmentation achieves high concentration factors (150-fold or more) through a systematic approach that is easier to operate and maintain than a single complex high-concentration step.
Solution Approach 2:
The system uses porous membranes with precisely controlled MWCO values as the core separation mechanism. The porous structure of each membrane is optimized for its specific retention requirement, simplifying the overall design by relying on the inherent separation properties of the membrane materials rather than complex mechanical staging.
4Speed
If higher flow rates are used in SPTFF, then processing speed improves, but achieving high concentration factors becomes more difficult
Solution Approach 1:
The concentration process is segmented into multiple passes through the membrane series. Each pass operates at high flow rate for speed, while the cumulative effect of multiple stages achieves the high concentration factor. The system processes large volumes quickly through parallel flow paths while maintaining high concentration capability through the series membrane arrangement.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables concentration factors of up to 150-fold and operation at flow rates 2-4 times higher than traditional configurations, reducing processing time and minimizing membrane fouling, thus enhancing the efficiency of protein concentration in biotechnology and biopharmaceutical applications.
Implementation Method 1
passing the solution through a hybrid configuration of semi-permeable membranes staged in series in a SPTFF apparatus
Data Source
AI summary
This disclosure provides a method for concentrating a solution of a macromolecule that is retained on at least two semi-permeable membranes that have different molecular weight cutoffs (MWCOs), the method comprising passing the solution through a hybrid configuration of said semi-permeable membranes staged in series in a single pass tangential flow filtration (SPTFF) apparatus. The method is applicable to the efficient concentration of biological macromolecules such as proteins, antibodies and nucleic acids.